Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer

Description:

We will evaluate how FAPI PET/MRI correlates with histopathological assessment, the method's ability to grade tumors - including assessment of treatment - compared to CT, scintigraphy and FDG PET/CT, and ability to detect local recurrence.

Sponsor:

St. Olav's Hospital

Contacts:

TBD

tbd@tbd.com

tbd

18F-FAPI

Isotope(s):
Target(s):
  • FAP
XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468